Cristal Therapeutics
The company develops and licenses a proprietary copper-free click chemistry reagent known as CliCr. This technology is designed to provide higher stability and faster reaction times for the generation of bioconjugate products. The business model focuses on offering this technology to partners under license agreements for use in various diagnostic and therapeutic applications.
Biotechnology
Life Sciences
Diagnostics
Therapeutics
Funding summary
- Total raised
- €6.0M
- Funding rounds
- 1
Investors in Cristal Therapeutics
Investors on record for Cristal Therapeutics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Cristal Therapeutics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors